Institute of Oncology Research
In research, Institute of Oncology Research stands highest in Medicine (#7,005 of 10,443 worldwide) and Health Sciences (#8,757 of 11,982 worldwide), 2022–2025. Relative to its size it is most specialised in Molecular Biology — Molecular Biology is 5.3× its share of world research.
- World rank, 2022–2025
- #9,842 of 28,054 · #4,567 all time
- Rank in Switzerland
- #61 of 220
- Research works
- 850 ▼ 23% vs 2013–17
- Citations
- 36k 42.0 per fractional work
- Top-10% rate
- 17.1% record average 16.5%
- Open access
- 42% world 28%
What is Institute of Oncology Research known for in research?
The fields where it stands highest, 2022–2025, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works | All time |
|---|---|---|---|---|---|
| MedicineField | #7,005 of 10,443 | 16.4% | 89 | #3284 | |
| Health SciencesDomain | #8,757 of 11,982 | 16.5% | 90 | #4555 |
Each strip is that field’s whole ranked pool, with the notch where Institute of Oncology Research sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
What does Institute of Oncology Research specialise in?
Where its research is concentrated relative to its size: Molecular Biology takes 5.3× the share of its output that it takes of world research.
- Molecular BiologySubfield · 22.5 works5.3×
Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 4.6×. Every wedge is a field page.
- Biochemistry, Genetics and Molecular Biology 4.6×
- Immunology and Microbiology 3.8×
- Medicine 3.3×
- Veterinary 0.7×
- Neuroscience 0.7×
- Chemistry 0.7×
- Physics and Astronomy 0.3×
- Nursing 0.3×
- Mathematics 0.3×
- Pharmacology, Toxicology and Pharmaceutics 0.3×
- Environmental Science 0.2×
- Health Professions 0.2×
- Business, Management and Accounting 0.2×
- Dentistry 0.1×
- Psychology 0.1×
- Engineering 0.1×
- Decision Sciences 0.1×
- Economics, Econometrics and Finance 0.1×
- Agricultural and Biological Sciences 0.0×
- Materials Science 0.0×
- Computer Science 0.0×
- Social Sciences 0.0×
Who are the top researchers at Institute of Oncology Research?
Ranked on the composite score, Franco Cavalli, Michele Ghielmini and Cristiana Sessa lead among researchers whose main affiliation is Institute of Oncology Research.
- 1 Franco Cavalli Switzerland · #42,694 worldwide 297 citations · 46 works
- 2 Michele Ghielmini Switzerland · #43,075 worldwide 948 citations · 30 works
- 3 Cristiana Sessa Switzerland · #145,026 worldwide 230 citations · 51 works
- 4 Emanuele Zucca Switzerland · #146,334 worldwide 476 citations · 124 works
- 5 Luca Giovanella Switzerland · #163,304 worldwide 144 citations · 52 works
- 6 Sara De Dosso Switzerland · #210,083 worldwide 130 citations · 21 works
- 7 Eugenio Gaudio Switzerland · #251,113 worldwide 151 citations · 27 works
- 8 Davide Rossi Switzerland · #315,206 worldwide 253 citations · 131 works
- 9 Luca Ceriani Switzerland · #519,666 worldwide 57 citations · 33 works
- 10 Francesco Bertoni Switzerland · #531,918 worldwide 298 citations · 153 works
Which keywords describe research at Institute of Oncology Research?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Rituximab, PET Imaging, Lymphoma, Prognostic Factors, Gene Expression Profiling, Molecular Profiling, Classification and Genetic Pathogenesis.
- Dosimetry
- Tumor Regression
- Cancer Treatment
- Genomic Instability
- Molecular Characterization
- Clinical Guidelines
- Breast Cancer
- Metastatic Prostate Cancer
- Androgen Receptor
- Genomic Profiling
- Prostate Cancer
- Biomarkers
- Genomic Aberrations
- Clinical Trials
- Chemotherapy
- Immunotherapy
- Genetic Pathogenesis
- Molecular Profiling
- Prognostic Factors
- PET Imaging
- Rituximab
- Lymphoma
- Gene Expression Profiling
- Classification
- Hodgkin's Lymphoma
- Cancer
- Therapeutic Targets
- Chronic Lymphocytic Leukemia
- Genetic Mutations
- Targeted Therapy
- Cancer Therapy
- Tumor Microenvironment
- Hormone Therapy
- Molecular Biology
- Transcriptional Regulation
- Gene Expression
- Radiotherapy
- Epigenetic Regulation
- Metastatic
- Cancer Immunotherapy
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Rituximab21▲ 101×3 topics
- PET Imaging16▲ 68×4 topics
- Lymphoma15▲ 68×3 topics
- Prognostic Factors14▲ 22×14 topics
- Gene Expression Profiling13▲ 115×2 topics
- Molecular Profiling13▲ 95×2 topics
- Classification13▲ 20×2 topics
- Genetic Pathogenesis13▲ 168×1 topic
- Hodgkin's Lymphoma13▲ 168×1 topic
- Immunotherapy12▲ 12×17 topics
- Cancer11▲ 6.0×33 topics
- Chemotherapy10▲ 10×20 topics
- Therapeutic Targets9▲ 40×5 topics
- Clinical Trials8▲ 9.0×8 topics
- Chronic Lymphocytic Leukemia8▲ 130×1 topic
- Genomic Aberrations8▲ 130×1 topic
- Genetic Mutations8▲ 13×12 topics
- Biomarkers8▲ 8.0×10 topics
- Targeted Therapy8▲ 25×5 topics
- Prostate Cancer7▲ 40×5 topics
- Cancer Therapy7▲ 8.7×15 topics
- Genomic Profiling7▲ 48×2 topics
- Tumor Microenvironment6▲ 8.8×8 topics
- Androgen Receptor5▲ 47×2 topics
- Hormone Therapy5▲ 42×2 topics
- Metastatic Prostate Cancer5▲ 81×1 topic
- Molecular Biology5▲ 80×1 topic
- Breast Cancer4▲ 13×8 topics
- Transcriptional Regulation4▲ 18×8 topics
- Clinical Guidelines4▲ 10.0×5 topics
- Gene Expression4▲ 4.7×11 topics
- Molecular Characterization4▲ 16×3 topics
- Radiotherapy4▲ 7.2×11 topics
- Genomic Instability4▲ 24×3 topics
- Epigenetic Regulation4▲ 12×5 topics
- Cancer Treatment3▲ 10.0×7 topics
- Metastatic3▲ 37×2 topics
- Tumor Regression3▲ 21×2 topics
- Cancer Immunotherapy3▲ 14×3 topics
- Dosimetry3▲ 32×2 topics
Which research topics does Institute of Oncology Research publish most on?
By volume in 2022–2025: Lymphoma Diagnosis and Treatment, Chronic Lymphocytic Leukemia Research, Prostate Cancer Treatment and Research and Cancer Genomics and Diagnostics.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Lymphoma Diagnosis and Treatment Pathology and Forensic Medicine 13 works
- 2 Chronic Lymphocytic Leukemia Research Genetics 8 works
- 3 Prostate Cancer Treatment and Research Pulmonary and Respiratory Medicine 5 works
- 4 Cancer Genomics and Diagnostics Cancer Research 3 works
- 5 CAR-T cell therapy research Oncology 3 works
- 6 Prostate Cancer Diagnosis and Treatment Pulmonary and Respiratory Medicine 2 works
- 7 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 2 works
- 8 Cancer Immunotherapy and Biomarkers Oncology 2 works
- 9 Radiopharmaceutical Chemistry and Applications Radiology, Nuclear Medicine and Imaging 2 works
- 10 RNA modifications and cancer Molecular Biology 2 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Institute of Oncology Research's research output changed?
Output in 2018–2022 was 23% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Bellinzona
- Ente Ospedaliero Cantonale
- Ospedale San Giovanni Bellinzona
- Ospedale Regionale di Bellinzona e Valli
- Repubblica e Cantone Ticino
- Federal Criminal Court
- Scuola Cantonale di Commercio Bellinzona
- Vir Biotechnology (Switzerland)
- International Extranodal Lymphoma Study Group
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.